In Q1 of this year, I sat down with Meredith, CFO at Corsera Health, to discuss the future of cardiovascular health and why prediction and prevention are becoming increasingly important in improving outcomes long before a CVD diagnosis.We explored what it takes to build a company at the intersection of science, data and healthcare, how finance and strategy support innovation.A really insightful conversation with Meredith on the opportunities and challenges of building a company focused on tackling one of the world's leading causes of death.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Max Brennan - Biotech HeadHunter. Innehållet i podden är skapat av Max Brennan - Biotech HeadHunter och inte av, eller tillsammans med, Poddtoppen.